| Spotlight |
 |
|
Following the positive outcome, Pfizer and Astellas will seek approval of Padcev-Keytruda in MIBC regardless of a patient’s cisplatin eligibility.
|
| Latest news |
|
|
If approved, gene therapies could fill gaps in patient care left by CFTR modulators, notes GD Healthcare analyst, Vinie Varkey.
|
|
|
The centre is equipped with a dedicated research team, six private exam rooms, 14 infusion bays, and a pharmacokinetic lab.
|
|
|
Targeted patient recruitment can increase the likelihood of trial success and help cultivate use of precision medicine.
|
|
|
Over-65s are most vulnerable to dying from influenza, and those aged 85 and older have the highest hospitalisation rates.
|
|
|
The clinical study is divided into two parts: a Phase I dose escalation stage and a Phase IIa dose expansion and optimisation stage.
|
|
|
|
